SciELO - Scientific Electronic Library Online

 
vol.27 suppl.1Pharmacological treatment of scleroderma renal crisis: A systematic literature reviewPharmacological treatment of systemic sclerosis-associated pulmonary hypertension: A systematic literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

REYES-MARTINEZ, Viviana et al. Mesenchymal stromal cells represent a therapeutic option for systemic sclerosis patients. Rev.Colomb.Reumatol. [online]. 2020, vol.27, suppl.1, pp.126-134.  Epub Aug 23, 2021. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2020.02.007.

The mesenchymal stromal cells (MSCs) are hematopoietic stem cells with high capacity of differentiation to other cellular lineages, depending on the microenvironment in which they live as well as on the interaction and signaling pathways they establish with the extracellular matrix. Several properties have been described in these cells: proangiogenic, antifibrotic and immunomodulatory. These properties are being studied as a therapeutic approach for autoimmune diseases such as cutaneous systemic sclerosis (SSc). SSc is a systemic chronic disease, with an approximate prevalence of 35.6 cases per 100,000 inhabitants in North America and of 0.02% in Colombia in 2018. There are two different clinical variants, diffuse and localized. In both variants an important skin involvement and a rapidly deterioration of organs is present, which can overshadow the clinical prognosis and increase the mortality. Options for the treatment of advanced diffuse SSc are scarce mainly targeting symptomatic control with little impact on the progression and mortality. Therefore, there is an increasing interest in new therapies like advanced cellular therapy with hematopoietic stem cells and stromal mesenchymal cells. This article reviews the information related to the use of stromal mesenchymal cells in patients with this disease.

Keywords : Mesenchymal stromal cells; Diffuse systemic sclerosis; Limited systemic sclerosis; Hematopoietic stem cells; Advanced cell therapy.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )